Latest News and Press Releases

SAN DIEGO, Jan. 02, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on...

-  Acquisition expands ResMed’s SaaS business to Germany, first non-U.S. market -  Outpatient therapy services added to ResMed’s growing SaaS offering portfolio -  Purchase price of €958.6 million...

New 270,000-square-foot (25,000-square-meter) facility in Tuas marks the next stage in ResMed’s more than decade-long presence in Singapore; will account for nearly 1,000 jobs across a variety of...

Year-over-year revenue grows 5%, operating profit up 5%, non-GAAP operating profit up 4% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today...

SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2023 on Thursday,...

SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bank of America Global...

SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the 20th Annual...

New prevalence figure 22–126% higher than previous estimatesPrevalence expected to reach 592 million by 2050Researchers urge global action on smoking cessation and air pollution reduction ...

Year-over-year revenue grows 4%, operating profit up 6%, non-GAAP operating profit up 4%Quarterly dividend increases 5% to $0.44 per share Note: A webcast of ResMed’s conference call will be...

Acquisition lays foundation to build ResMed’s digital sleep medicine portfolio in Germanysomnio digital health application focused on improving sleep in patients with diagnosed insomnia, filling care...